A citation-based method for searching scientific literature

K R Bowles, S P Brooks, S B Dunnett, L Jones. Brain Res Bull 2012
Times Cited: 21







List of co-cited articles
237 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.
L Mangiarini, K Sathasivam, M Seller, B Cozens, A Harper, C Hetherington, M Lawton, Y Trottier, H Lehrach, S W Davies,[...]. Cell 1996
57

Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.
M DiFiglia, E Sapp, K O Chase, S W Davies, G P Bates, J P Vonsattel, N Aronin. Science 1997
42

Neuropathological classification of Huntington's disease.
J P Vonsattel, R H Myers, T J Stevens, R J Ferrante, E D Bird, E P Richardson. J Neuropathol Exp Neurol 1985
38

Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage.
Alexandre Kuhn, Darlene R Goldstein, Angela Hodges, Andrew D Strand, Thierry Sengstag, Charles Kooperberg, Kristina Becanovic, Mahmoud A Pouladi, Kirupa Sathasivam, Jang-Ho J Cha,[...]. Hum Mol Genet 2007
256
33

Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease.
Elizabeth J Slow, Jeremy van Raamsdonk, Daniel Rogers, Sarah H Coleman, Rona K Graham, Yu Deng, Rosemary Oh, Nagat Bissada, Sazzad M Hossain, Yu-Zhou Yang,[...]. Hum Mol Genet 2003
598
33

Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice.
Michelle Gray, Dyna I Shirasaki, Carlos Cepeda, Véronique M André, Brian Wilburn, Xiao-Hong Lu, Jifang Tao, Irene Yamazaki, Shi-Hua Li, Yi E Sun,[...]. J Neurosci 2008
458
33

Transgenic rat model of Huntington's disease.
Stephan von Hörsten, Ina Schmitt, Huu Phuc Nguyen, Carsten Holzmann, Thorsten Schmidt, Thomas Walther, Michael Bader, Reinhard Pabst, Philipp Kobbe, Jana Krotova,[...]. Hum Mol Genet 2003
254
28

Executive and mnemonic functions in early Huntington's disease.
A D Lawrence, B J Sahakian, J R Hodges, A E Rosser, K W Lange, T W Robbins. Brain 1996
284
28

Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice.
Mahmoud A Pouladi, Lisa M Stanek, Yuanyun Xie, Sonia Franciosi, Amber L Southwell, Yu Deng, Stefanie Butland, Weining Zhang, Seng H Cheng, Lamya S Shihabuddin,[...]. Hum Mol Genet 2012
107
28

Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.
S W Davies, M Turmaine, B A Cozens, M DiFiglia, A H Sharp, C A Ross, E Scherzinger, E E Wanker, L Mangiarini, G P Bates. Cell 1997
23

Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease.
Christian Landles, Kirupa Sathasivam, Andreas Weiss, Ben Woodman, Hilary Moffitt, Steve Finkbeiner, Banghua Sun, Juliette Gafni, Lisa M Ellerby, Yvon Trottier,[...]. J Biol Chem 2010
226
23

Evidence for specific cognitive deficits in preclinical Huntington's disease.
A D Lawrence, J R Hodges, A E Rosser, A Kershaw, C ffrench-Constant, D C Rubinsztein, T W Robbins, B J Sahakian. Brain 1998
312
23

Selective extra-dimensional set shifting deficit in a knock-in mouse model of Huntington's disease.
S P Brooks, H Betteridge, R C Trueman, L Jones, S B Dunnett. Brain Res Bull 2006
36
23

Neurological abnormalities in a knock-in mouse model of Huntington's disease.
C H Lin, S Tallaksen-Greene, W M Chien, J A Cearley, W S Jackson, A B Crouse, S Ren, X J Li, R L Albin, P J Detloff. Hum Mol Genet 2001
447
23

Regional and cellular gene expression changes in human Huntington's disease brain.
Angela Hodges, Andrew D Strand, Aaron K Aragaki, Alexandre Kuhn, Thierry Sengstag, Gareth Hughes, Lyn A Elliston, Cathy Hartog, Darlene R Goldstein, Doris Thu,[...]. Hum Mol Genet 2006
541
23

Huntington's disease: can mice lead the way to treatment?
Zachary R Crook, David Housman. Neuron 2011
158
23

Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice.
Robert J Ferrante, James K Kubilus, Junghee Lee, Hoon Ryu, Ayshe Beesen, Birgit Zucker, Karen Smith, Neil W Kowall, Rajiv R Ratan, Ruth Luthi-Carter,[...]. J Neurosci 2003
495
23

Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation.
R J Carter, L A Lione, T Humby, L Mangiarini, A Mahal, G P Bates, S B Dunnett, A J Morton. J Neurosci 1999
706
23

Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse.
V C Wheeler, W Auerbach, J K White, J Srinidhi, A Auerbach, A Ryan, M P Duyao, V Vrbanac, M Weaver, J F Gusella,[...]. Hum Mol Genet 1999
282
23

Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease.
Jeremy M Van Raamsdonk, Jacqueline Pearson, Elizabeth J Slow, Sazzad M Hossain, Blair R Leavitt, Michael R Hayden. J Neurosci 2005
237
23

Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation.
L A Lione, R J Carter, M J Hunt, G P Bates, A J Morton, S B Dunnett. J Neurosci 1999
285
23

Molecular mechanisms and potential therapeutical targets in Huntington's disease.
Chiara Zuccato, Marta Valenza, Elena Cattaneo. Physiol Rev 2010
575
23

Huntington's disease.
Francis O Walker. Lancet 2007
19


Longitudinal analysis of the behavioural phenotype in Hdh(CAG)150 Huntington's disease knock-in mice.
Simon Brooks, Gemma Higgs, Lesley Jones, Stephen B Dunnett. Brain Res Bull 2012
43
19

Selective cognitive impairment in the YAC128 Huntington's disease mouse.
Simon P Brooks, Nari Janghra, Gemma V Higgs, Zubeyde Bayram-Weston, Andreas Heuer, Lesley Jones, Stephen B Dunnett. Brain Res Bull 2012
38
19

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease.
Emma Hockly, Victoria M Richon, Benjamin Woodman, Donna L Smith, Xianbo Zhou, Eddie Rosa, Kirupa Sathasivam, Shabnam Ghazi-Noori, Amarbirpal Mahal, Philip A S Lowden,[...]. Proc Natl Acad Sci U S A 2003
639
19

Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease.
Gabriella Gardian, Susan E Browne, Dong-Kug Choi, Peter Klivenyi, Jason Gregorio, James K Kubilus, Hoon Ryu, Brett Langley, Rajiv R Ratan, Robert J Ferrante,[...]. J Biol Chem 2005
339
19

Brain gene expression correlates with changes in behavior in the R6/1 mouse model of Huntington's disease.
A Hodges, G Hughes, S Brooks, L Elliston, P Holmans, S B Dunnett, L Jones. Genes Brain Behav 2008
44
19

The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice.
Elizabeth A Thomas, Giovanni Coppola, Paula A Desplats, Bin Tang, Elisabetta Soragni, Ryan Burnett, Fuying Gao, Kelsey M Fitzgerald, Jenna F Borok, David Herman,[...]. Proc Natl Acad Sci U S A 2008
214
19

Evaluation of histone deacetylases as drug targets in Huntington's disease models. Study of HDACs in brain tissues from R6/2 and CAG140 knock-in HD mouse models and human patients and in a neuronal HD cell model.
Luisa Quinti, Vanita Chopra, Dante Rotili, Sergio Valente, Allison Amore, Gianluigi Franci, Sarah Meade, Marta Valenza, Lucia Altucci, Michele M Maxwell,[...]. PLoS Curr 2010
30
19

Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models.
Ghazaleh Sadri-Vakili, Bérengère Bouzou, Caroline L Benn, Mee-Ohk Kim, Prianka Chawla, Ryan P Overland, Kelly E Glajch, Eva Xia, Zhihua Qiu, Steven M Hersch,[...]. Hum Mol Genet 2007
159
19

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease.
C Zuccato, A Ciammola, D Rigamonti, B R Leavitt, D Goffredo, L Conti, M E MacDonald, R M Friedlander, V Silani, M R Hayden,[...]. Science 2001
947
19

Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules.
Laurent R Gauthier, Bénédicte C Charrin, Maria Borrell-Pagès, Jim P Dompierre, Hélène Rangone, Fabrice P Cordelières, Jan De Mey, Marcy E MacDonald, Volkmar Lessmann, Sandrine Humbert,[...]. Cell 2004
810
19

Huntington disease and the huntingtin protein.
Zhiqiang Zheng, Marc I Diamond. Prog Mol Biol Transl Sci 2012
69
19

Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis.
Holly B Kordasiewicz, Lisa M Stanek, Edward V Wancewicz, Curt Mazur, Melissa M McAlonis, Kimberly A Pytel, Jonathan W Artates, Andreas Weiss, Seng H Cheng, Lamya S Shihabuddin,[...]. Neuron 2012
500
19

What have we learned from gene expression profiles in Huntington's disease?
Tamara Seredenina, Ruth Luthi-Carter. Neurobiol Dis 2012
103
19

Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity.
A Giralt, M Puigdellívol, O Carretón, P Paoletti, J Valero, A Parra-Damas, C A Saura, J Alberch, S Ginés. Hum Mol Genet 2012
105
19


The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription.
J S Steffan, A Kazantsev, O Spasic-Boskovic, M Greenwald, Y Z Zhu, H Gohler, E E Wanker, G P Bates, D E Housman, L M Thompson. Proc Natl Acad Sci U S A 2000
799
19

Huntington disease.
J P Vonsattel, M DiFiglia. J Neuropathol Exp Neurol 1998
19

Light and electron microscopic characterization of the evolution of cellular pathology in YAC128 Huntington's disease transgenic mice.
Zubeyde Bayram-Weston, Lesley Jones, Stephen B Dunnett, Simon P Brooks. Brain Res Bull 2012
31
14


Subtle but progressive cognitive deficits in the female tgHD hemizygote rat as demonstrated by operant SILT performance.
Simon Brooks, Steven Fielding, Màtè Döbrössy, Stephan von Hörsten, Stephen Dunnett. Brain Res Bull 2009
15
20

Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington's disease.
Huu Phuc Nguyen, Philipp Kobbe, Henning Rahne, Till Wörpel, Burkard Jäger, Michael Stephan, Reinhard Pabst, Carsten Holzmann, Olaf Riess, Hubert Korr,[...]. Hum Mol Genet 2006
94
14


Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain.
Ruth Luthi-Carter, Sarah A Hanson, Andrew D Strand, Donald A Bergstrom, Wanjoo Chun, Nikki L Peters, Annette M Woods, Edmond Y Chan, Charles Kooperberg, Dimitri Krainc,[...]. Hum Mol Genet 2002
298
14

Expression profiling of Huntington's disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration.
Andrew D Strand, Zachary C Baquet, Aaron K Aragaki, Peter Holmans, Lichuan Yang, Carine Cleren, M Flint Beal, Lesley Jones, Charles Kooperberg, James M Olson,[...]. J Neurosci 2007
164
14

A combination drug therapy improves cognition and reverses gene expression changes in a mouse model of Huntington's disease.
A Jennifer Morton, Mark J Hunt, Angela K Hodges, Paul D Lewis, Amanda J Redfern, Stephen B Dunnett, Lesley Jones. Eur J Neurosci 2005
56
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.